Medicare Benefits Schedule - Note TN.8.42

Search Results for Note TN.8.42

View Related Items

Category 3 - THERAPEUTIC PROCEDURES

TN.8.42

Colposcopic Examination - (Item 35614)

It should be noted that colposcopic examination (screening) of a person during the course of a consultation does not attract Medicare benefits under Item 35614 except in the following circumstances:  

(a) where the patient has had an abnormal cervical screen result;

(b) where there is a history of ingestion of oestrogen by the patient's mother during their pregnancy;  or

(c) where the patient has been referred by another medical practitioner because of suspicious signs of genital cancer.

Related Items: 35614


Related Items

Category 3 - THERAPEUTIC PROCEDURES

35614

35614 - Additional Information

Item Start Date:
01-Mar-2022
Description Updated:
01-Mar-2022
Schedule Fee Updated:
01-Jul-2023

Examination of the lower genital tract using a colposcope in a patient who:
(a) has a human papilloma virus related gynaecology indication; or
(b) has symptoms or signs suspicious of lower genital tract malignancy; or
(c) is undergoing follow-up treatment of lower genital tract malignancy; or
(d) is undergoing assessment or surveillance of a vulvovaginal pre-malignant or malignant disease; or
(e) is undergoing assessment or surveillance as part of an identified at risk population

Fee: $69.95 Benefit: 75% = $52.50 85% = $59.50

(See para TN.8.42, TN.8.233 of explanatory notes to this Category)


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change